Extrapancreatic effects of hypoglycemic sulfonylureas: still a controversial issue

This publication has 20 references indexed in Scilit:

• Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal
  Diabetes, 1984
• Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics
  Diabetes, 1982
• Insulin plus Sulfonylharnstoff- eine (un)mögliche Kombination?
  Deutsche Medizinische Wochenschrift (1946), 1982
• Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
  BMJ, 1981
• INCREASED INSULIN SENSITIVITY AND CELLULAR INSULIN BINDING IN OBESE DIABETICS FOLLOWING TREATMENT WITH GLIBENCLAMIDE
  Acta Endocrinologica, 1979
• Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients
  The American Journal of Medicine, 1976
• EFFECT OF SHORT AND LONG TERM CHLORPROPAMIDE TREATMENT ON INSULIN RELEASE AND BLOOD-GLUCOSE
  The Lancet, 1974
• Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action
  Diabetes, 1971
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus
  Diabetes, 1967
• Treatment of the obese diabetic
  Metabolism, 1967